The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double‐blind, placebo‐controlled study
Abstract
Objective: To evaluate the clinical response, safety, and tolerability of a single intraarticular injection of anakinra in patients with symptomatic osteoarthritis (OA) of the knee. Methods: Patients with OA of the knee were enrolled in a multicenter, double‐blind, placebo‐controlled study and randomized 2:1:2 to receive a single intraarticular injection of placebo, anakinra 50 mg, or anakinra 150 mg in their symptomatic knee. Patients were evaluated for 12 weeks postinjection. The primary end point was the change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score from baseline to week 4. Safety assessments included the evaluation of adverse events (AEs), laboratory tests, and vital signs. Pharmacokinetic parameters were assessed in a subset of patients. Results: Of 170 patients who enrolled, 160 (94%) completed the study. The mean improvements from baseline to week 4 in the WOMAC score were not statistically different between the placebo group and the patients who received 50 mg of anakinra (P = 0.67) or 150 mg of anakinra (P = 0.77). Anakinra was well tolerated. No withdrawals due to AEs or serious AEs, and no serious infections or deaths were reported. No clinically significant trends were noted in laboratory values or vital signs. Pharmacokinetic parameters demonstrated that the mean terminal half‐life of anakinra in serum after intraarticular injection was ∼4 hours. Conclusion: Anakinra was well tolerated as a single 50‐mg or 150‐mg intraarticular injection in patients with OA of the knee. However, anakinra was not associated with improvements in OA symptoms compared with placebo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, T. D., Greenwald, R., Hochberg, M., et al. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290816 · Cited by 6,777
Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors
Felson, D. T., Lawrence, R. C., Dieppe, P. A., Hirsch, R., Helmick, C. G., Jordan, J. M., Kington, R. S., Lane, N. E., Nevitt, M. C., Zhang, Y., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00016 · Cited by 2,519
Jordan, K. M., Arden, N. K., Doherty, M., Bannwarth, B., Bijlsma, J. W. J., Dieppe, P., Gunther, K., Hauselmann, H., Herrero-Beaumont, G., Kaklamanis, P., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011742 · Cited by 2,048
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update
(2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1905::aid-anr1>3.0.co;2-p · Cited by 1,875
The prevalence of knee osteoarthritis in the elderly. the framingham osteoarthritis study
Felson, D. T., Naimark, A., Anderson, J., Kazis, L., Castelli, W., & Meenan, R. F. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300811 · Cited by 1,621
Zhang, W., Doherty, M., Leeb, B. F., Alekseeva, L., Arden, N. K., Bijlsma, J. W., Dinçer, F., Dziedzic, K., Häuselmann, H. J., Herrero-Beaumont, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062091 · Cited by 1,338
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
Clegg, D. O., Reda, D. J., Harris, C. L., Klein, M. A., O'Dell, J. R., Hooper, M. M., Bradley, J. D., Bingham, C. O., Weisman, M. H., Jackson, C. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052771 · Cited by 1,329
Felson, D. T., & McAlindon, T. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-1-200201010-00019 · Cited by 1,122
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
Arend, W. P., & Dayer, J. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330302 · Cited by 949
ANDERSON, J. J., & FELSON, D. T. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114939 · Cited by 892
Pham, T., van der Heijde, D., Altman, R. D., Anderson, J. J., Bellamy, N., Hochberg, M., Simon, L., Strand, V, Woodworth, T., & Dougados, M. (2004) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2004.02.001 · Cited by 849
Zhang, W., Doherty, M., Arden, N., Bannwarth, B., Bijlsma, J., Gunther, K.-P., Hauselmann, H. J., Herrero-Beaumont, G., Jordan, K., Kaklamanis, P., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.028886 · Cited by 785
Pavelká, K., Gatterová, J., Olejarová, M., Machacek, S., Giacovelli, G., & Rovati, L. C. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.18.2113 · Cited by 683
Dean, D. D., Martel-Pelletier, J., Pelletier, J. P., Howell, D. S., & Woessner, J. F. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114215 · Cited by 598
Altman, R. D., & Moskowitz, R. W. (1998) · PubMed · Cited by 443
Jiang, Y., Genant, H. K., Watt, I., Cobby, M., Bresnihan, B., Aitchison, R., & McCabe, D. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200005)43:5<1001::aid-anr7>3.0.co;2-p · Cited by 399
Pelletier, J., Caron, J. P., Evans, C., Robbins, P. D., Georgescu, H. I., Jovanovic, D., Fernandes, J. C., & Martel‐Pelletier, J. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400604 · Cited by 378
Caron, J. P., Fernandes, J. C., Martel‐Pelletier, J., Tardif, G., Mineau, F., Geng, C., & Pelletier, J. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390914 · Cited by 366
The natural history of cartilage defects in people with knee osteoarthritis
Davies-Tuck, M. L., Wluka, A. E., Wang, Y., Teichtahl, A. J., Jones, G., Ding, C., & Cicuttini, F. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.07.005 · Cited by 261
Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study
Cicuttini, F. M., Jones, G., Forbes, A., & Wluka, A. E. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.021253 · Cited by 248
In Vivo Transfer of Interleukin-1 Receptor Antagonist Gene in Osteoarthritic Rabbit Knee Joints
Fernandes, J., Tardif, G., Martel-Pelletier, J., Lascau-Coman, V., Dupuis, M., Moldovan, F., Sheppard, M., Krishnan, B. R., & Pelletier, J.-P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65368-0 · Cited by 219
Chevalier, X., Giraudeau, B., Conrozier, T., Marliere, J., Kiefer, P., & Goupille, P. (2005) · PubMed · Cited by 197
Self-citationSHINGU, M., NAGAI, Y., ISAYAMA, T., NAONO, T., NOBUNAGA, M., & NAGAI, Y. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05992.x · Cited by 170
Hughes, R., & Carr, A. (2002) · Rheumatology · doi:10.1093/rheumatology/41.3.279 · Cited by 165
Seckinger, P., Klein‐Nulend, J., Alander, C., Thompson, R. C., Dayer, J. M., & Raisz, L. G. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4181 · Cited by 154
Altman, R. D., Åkermark, C., Beaulieu, A. D., & Schnitzer, T. J. (2004) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2004.04.010 · Cited by 151
Self-citationWluka, A. E., Ding, C., Jones, G., & Cicuttini, F. (2005) · Rheumatology · doi:10.1093/rheumatology/kei018 · Cited by 150
Update of ACR Guidelines for Osteoarthritis
Schnitzer, T. J. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00372-x · Cited by 95
Pillinger, M. H. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70352-3 · Cited by 55
Vignon, E. P., Balblanc, J.-C., Mathieu, P., Louisot, P., & Richard, M. (1993) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(05)80026-3 · Cited by 43
(1988) · PubMed
Cited by
Glyn-Jones, S., Palmer, A. J. R., Agricola, R., Price, A. J., Vincent, T. L., Weinans, H., & Carr, A. J. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60802-3 · Cited by 3,151
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.-P., & Fahmi, H. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.196 · Cited by 2,778
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)
Berenbaum, F. (2013) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2012.11.012 · Cited by 1,718
Metadata
- Authors
- Chevalier, X., Goupille, P., Beaulieu, A. D., Burch, F. X., Bensen, W. G., Conrozier, T., Loeuille, D., Kivitz, A. J., Silver, D., & Appleton, B. E.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2009-02-26
- Volume
- 61
- Issue
- 3
- Pages
- 344-352
- ISSN
- 0893-7524 (ISSN-L)
- 1529-0123
- OpenAlex
- W1997957358
- Cited by
- 533
- References
- 31
- FWCI
- 17.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.